TherapeuticsMD (TXMD) Cash from Operations (2010 - 2026)
TherapeuticsMD (TXMD) posted Cash from Operations of 944000.0 for Q1 2026, up 151.73% on a QoQ basis from 375000.0 in Q4 2025, and up 35.05% year-over-year from 699000.0 in Q1 2025.
TherapeuticsMD (TXMD) Cash from Operations (2010 - 2026) Analysis & Trends
TherapeuticsMD's Cash from Operations history runs 17 years deep, the most recent figure standing at 944000.0 for Q1 2026.
- Quarterly Cash from Operations rose 35.05% year-over-year to 944000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2699000.0 (up 28.65% YoY) and the FY2025 annual result came in at 2454000.0, up 109.74% from the prior year.
- Cash from Operations was 944000.0 for Q1 2026 at TherapeuticsMD, up from 375000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 30236000.0 in Q4 2022 and bottomed at 20721000.0 in Q2 2022.
- A 5-year average of 538470.59 and a median of 17000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations slumped 134.03% — and 2025, when it surged 2105.88%.
- TherapeuticsMD's Cash from Operations stood at 30236000.0 in 2022, then plunged by 116.4% to 4960000.0 in 2023, then soared by 100.34% to 17000.0 in 2024, then jumped by 2105.88% to 375000.0 in 2025, then soared by 151.73% to 944000.0 in 2026.
- Business Quant data shows TXMD's Cash from Operations at 944000.0 in Q1 2026, 375000.0 in Q4 2025, and 999000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | 944,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944,000.00 |
| Mar 31, 2026 | 944,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | -229,000.00 |
| Mar 31, 2024 | -229,000.00 |
| Dec 31, 2023 | -4.96 Mn |
| Dec 31, 2023 | -4.96 Mn |